- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Patent
Emerging markets give Lilly hope in patent crunch
February 19, 2011
J.K. WallIn a kind of alternate drug universe, sales of Eli Lilly and Co.’s ghosts of blockbusters past are soaring in China—prompting
the drugmaker to pour money into emerging markets in an attempt to prop up revenue.
MoreVanderbilt rejected by high court on Cialis patents
January 24, 2011
Bloomberg NewsSupreme Court justices on Monday left intact a ruling throwing out a lawsuit pressed by the Nashville, Tenn., university against
Eli Lilly's Icos subsidiary.
MoreEli Lilly puts faith in drug pipeline
December 24, 2010
J.K. WallEli Lilly and Co. started to tip over its massive “patent cliff” this year, yet announced little publicly that
will significantly soften its inevitable sales plunge.
MoreHillenbrand wins ban of knockoff coffins from Mexico
December 14, 2010
Bloomberg NewsThe U.S. International Trade Commission said Monday that Ataudes Aguilares will be barred from bringing in caskets with attached
memorabilia compartments, which Batesville-based Hillenbrand has patented.
MorePhase 10 inventor folds in dispute over top-selling card game
November 22, 2010
Cory SchoutenThe inventor of the world's second-best-selling card game has settled a lawsuit with Fundex Games, the Plainfield company
that markets and distributes Phase 10.
MoreLilly scores series of small victories
November 17, 2010
J.K. WallThe Indianapolis-based drugmaker finally won FDA approval for its antidepressant Cymbalta to treat chronic pain and fended
off a patent challenge to rising-star cancer drug Alimta, but got a ratings downgrade on its debt.
MoreCourt upholds Lilly patent on cancer drug Alimta
November 16, 2010
IBJ Staff and Associated PressA U.S. District Court judge on Monday upheld Eli Lilly and Co.’s patent on the cancer drug Alimta, protecting the compound
until July 2016. It was a welcome win after a difficult few months for Indianapolis-based Lilly, which is facing a wave of
patent expirations in coming years.
MoreAppeals court rejects Lilly over Gemzar patent
November 1, 2010
IBJ Staff and Bloomberg NewsWithout an appeal, generic drugs are now poised to wipe away most of Lilly's $750 million in annual U.S. revenue from Gemzar.
MoreAppeals court ruling upholds Lilly's Evista patents
September 1, 2010
Bloomberg NewsEli Lilly and Co. won a court ruling Wednesday that blocks plans by Teva Pharmaceutical Industries Ltd. to sell a generic
version of the Evista osteoporosis treatment before March 2014.
MoreLilly braces for plunge in profits
August 14, 2010
J.K. WallIndianapolis-based drugmaker Eli Lilly and Co. faces such an unprecedented string of patent expirations and an unheard-of
loss of revenue that it's hard to picture what the company will look like in five years.
MoreEli Lilly loses patent lawsuit for Strattera
August 13, 2010
IBJ Staff and Associated PressEli Lilly and Co. on Thursday lowered its revenue outlook for the year after it lost a patent lawsuit over its attention
deficit hyperactivity drug Strattera. The patent had been set to expire in May 2017. Lilly plans to appeal.
MoreRoche hit with new breed of patent suit
August 11, 2010
J.K. WallRoche Diagnostics, a Swiss company that keeps its U.S. headquarters in Indianapolis, has been sued for marking its Accu-Chek
blood glucose monitors and accessories with patents that are expired. Illinois resident David O’Neill has sued on behalf
of the U.S. government to recover damages of $500 per infraction.
MoreCourt defeat lost in Lilly's gloomy long-term outlook
August 9, 2010
J.K. WallEli Lilly and Co.'s loss of a patent on one of its blockbuster drugs in court late last month received a collective yawn
from
investors, who have shunned the stock because of five looming patent expirations.
MoreHoosier firms that rely on innovation pine for patent reform
June 26, 2010
J.K. WallOne key change would grant patents to the first inventor to file an application, not the first who can prove to have made
the invention first.
MoreHillenbrand unit seeks to block imports of knockoff coffins
June 11, 2010
Bloomberg NewsHillenbrand Inc.'s Batesville unit, the largest U.S. maker of coffins,wants the trade commission to prevent Ataudes Aguilares
from selling its products in the United States and Puerto Rico.
MoreLilly sues to block copy of Evista osteoporosis drug
May 5, 2010
Bloomberg NewsWatson Pharmaceuticals filed for FDA approval to sell a low-cost version of Eli Lilly and Co.'s osteoporosis medicine. Indianapolis-based
Lilly is seeking a court order that would block approval until three of its patents expire in 2017.
MoreAnderson tech firm One Number files patent suit against Google
April 24, 2010
Chris O'MalleyAn Anderson firm that provides a “one number” service that rings all of a client’s phones has filed suit
against Web giant Google, alleging Google Voice infringes on two of its patents.
MoreNoblesville company has high hopes for pomegranate
April 10, 2010
Kathleen McLaughlinVerdure Sciences, a botanical-extract distributor, has invested more than $1 million in marketing and research,
and hopes to see its product in more
foods and drinks, perhaps even mouthwash.
MoreLocal attorney sues Fundex over game royalties
March 29, 2010
A local lawyer who created the game "Chronology" alleges breach of contract, trademark infringement, use of a counterfeit
mark, unfair competition, copyright infringement, trademark dilution and forgery.
MoreLilly sues to block generic of Adcirca lung treatment
March 17, 2010
Bloomberg NewsNetherlands-based Synthon Pharmaceuticals is seeking U.S. Food and Drug Administration approval to sell a copy of the medicine.
MoreIntellectual property practices in law firms recovering from recession
February 27, 2010
Norm HeikensPractices are beginning to thaw along with other areas of the economy.
MorePfizer's Viagra patent partially rejected in Lilly fight
February 16, 2010
Bloomberg NewsThe patent on impotence drug Viagra was partially rejected after the U.S. Patent and Trademark Office said it wasn't different
enough from a Chinese herb known as Horny Goat Weed. The patent was key to an infringement suit Pfizer filed in 2002 against
Eli Lilly and Co. over its rival Cialis drug.
MorePTS sues Roche Diagnostic to end blood-monitor royalties
February 13, 2010
J.K. WallPolymer Technology Systems Inc., a small Indianapolis-based maker of handheld blood monitors, has gone to court to fight
a competitor more than 100 times its size: Roche Diagnostics Corp.
MoreDow Agro in legal skirmish over canola oil
January 14, 2010
Bloomberg NewsIndianapolis-based Dow AgroSciences LLC has sued Cooper Industries Plc in an effort to clarify its rights to make a canola-based
fluid used in electrical transformers.
MoreEngineer doubles as inventor
December 26, 2009
Brock BenefielHidden Toilet Paper, a small business in Fishers, patented a device that installs toilet-paper rolls into walls, keeping paper
safe from pets and children.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Can IBJ please stop referring to this property as "Kessler Mansion"? What a ridiculous title for the biggest, bloated, blight in our city. It's not a mansion. At best, it's an ideal site to shoot low-budget porn. Ahhh! Another business use!
Its stories like these that prove that a Ball State diploma is worth less than the paper that its printed on. A real institution of higher learning would have taken care of this long ago. No way should this crap be taught in a SCIENCE class.
It is such a shame that King Ballard has made Indianapolis into Chicago south with all of the rampant corruption.
How many of these 1,259 bills were actually heard and voted on on the floor vs how many were shot down in committee?
When a an arrogant young guy with essentially no experience and no qualifications for the job, was dropped into an Administrator position out of nowhere by his "mentor" in the Mayor's office things seemed fishy. Sometimes things are what they seem.